Reprint

Advances in Parvovirus Research 2020

Edited by
November 2021
258 pages
  • ISBN978-3-0365-2490-0 (Hardback)
  • ISBN978-3-0365-2491-7 (PDF)

This book is a reprint of the Special Issue Advances in Parvovirus Research 2020 that was published in

Biology & Life Sciences
Medicine & Pharmacology
Public Health & Healthcare
Summary

Viruses of the Parvoviridae family constitute a most diverse and intriguing field of research. Parvoviruses can differ widely in their structure, genome organization and expression, virus–cell interactions, and impact on hosts. The translational implication of research on parvoviruses is relevant, since many viruses are important human and veterinary pathogens, while other viruses can be engineered as tools for oncolytic therapy or as sophisticated gene delivery vectors.

 

Exploring the diversity and inherent complexity in the biology of these apparently simple viruses is a still challenging topic for the scientific community. The Special Issue of Viruses is a collection of recent contributions in the field of parvovirus research, encompassing many aspects of basic and translational research on viruses of the family Parvoviridae, including on their structure, replication, and gene expression in addition to virus–host interactions and the development of vaccines and viral vectors.

Format
  • Hardback
License
© by the authors
Keywords
feline parvovirus; virus-like particles; VP2 protein; antibodies; AAV; neuro-degenerative disease; gene therapy; antigenicity; sequencing; virus; canine parvovirus; peri-urban; wild dogs; disease transmission; Australia; parvovirus B19; G-quadruplex; bioinformatics; antivirals; BRACO-19; pyridostatin; oncolytic viruses; rodent protoparvovirus H-1PV; virus entry; clathrin-mediated endocytosis; parvovirus; minute virus of mice; RNA processing; gene expression; canine; canine parvovirus; COVID-19; veterinary epidemiology; parvovirus B19; B19V; VP1u; receptor; PLA2; virus entry; erythroid cells; biomarker; drug delivery; nanocarrier; B19 parvovirus; detection; erythroid cells; cell cycle; permissivity; AAV; serotype; capsid; cryo-EM; genome packaging; gene delivery; bocavirus; capsid; parvovirus; cryo-EM; gene therapy; antigenicity; canine parvovirus; Caribbean region; new CPV-2a; outbreak; endemic; nearly complete genomes; virus evolution; parvoviruses; nucleus; imaging of viral interactions and dynamics; analysis of protein–protein interactions; analysis of virus–chromatin interactions; AMDV; Aleutian disease; mink parvovirus; Aleutian mink disease virus; vaccine